Literature DB >> 16573562

HLA-DRB1, -DQB1 alleles in head and neck carcinoma patients.

W J Koskinen1, J Partanen, A Vaheri, L-M Aaltonen.   

Abstract

Certain HLA class II alleles have been reported to play a role in development or prevention of cervical carcinoma, an epithelial malignancy linked to human papillomavirus (HPV). In head and neck carcinomas, of which a subset is also HPV associated, the impact of HLA genes remains unknown. HLA-DRB1, -DQB1 alleles were determined in a comprehensive series of 162 head and neck carcinoma patients, for which 83 consecutive cadaveric organ donors of Finnish origin served as controls. DRB1*03 was associated with node-negative disease and DRB1*08 and 13 with small tumors; DRB1*04 was protective against disease relapse. Most alleles of borderline significance in this study act similarly in cervical carcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16573562     DOI: 10.1111/j.1399-0039.2006.00558.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan.

Authors:  Otília Menyhárt; János Tibor Fekete; Balázs Győrffy
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

2.  Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma.

Authors:  Gerhard Dyckhoff; Christel Herold-Mende; Sabine Scherer; Peter K Plinkert; Rolf Warta
Journal:  Cancers (Basel)       Date:  2022-08-07       Impact factor: 6.575

3.  Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma.

Authors:  Takumi Kumai; Takayuki Ohkuri; Toshihiro Nagato; Yoshinari Matsuda; Kensuke Oikawa; Naoko Aoki; Shoji Kimura; Esteban Celis; Yasuaki Harabuchi; Hiroya Kobayashi
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.